Paid Clinical Trials in Alabama

Login to your account

Reset Password

Please Enter Username or Email

Create a free account

I'm a Participant
I'm an Organization

Showing 1 – 20 of 1091 results

A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)

by CTG

in NonSegmental Vitiligo

Other

Alabama

Deadline:

02/24/2027

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

by CTG

in Breast Neoplasms

Other

Alabama

Deadline:

07/14/2033

A Study to Investigate the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder

by CTG

in Generalized Tonic Clonic Seizure, CDKL5 Deficiency Disorder, Epileptic Spasm, Refractory Seizures

Other

Alabama

Deadline:

11/08/2027

Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C

by CTG

in Irritable Bowel Syndrome With Constipation (IBS-C)

Other

Alabama

Deadline:

10/01/2031

A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

by CTG

in Hypertension

Other

Alabama

Deadline:

04/05/2028

Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

by CTG

in Moderate-to-Severe Atopic Dermatitis

Other

Alabama

Deadline:

08/31/2026

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)

by CTG

in Human Papillomavirus Infection, Cervical Carcinoma

Other

Alabama

Deadline:

12/31/2026

A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

by CTG

in Chronic Migraine, Episodic Migraine

Other

Alabama

Deadline:

06/15/2027

Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)

by CTG

in Avascular Necrosis, Medication-related Osteonecrosis of the Jaw, Bisphosphonate-related Osteonecrosis of the Jaw

Other

Alabama

Deadline:

06/30/2026

A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease

by CTG

in Fabry Disease

Other

Alabama

Deadline:

12/06/2027

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

by CTG

in Cardiovascular Diseases, Coronary Artery Disease, In-Stent Restenosis

Other

Alabama

Deadline:

07/01/2028

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

by CTG

in Arteriosclerosis, Hypercholesterolaemia

Other

Alabama

Deadline:

11/29/2029

The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

by CTG

in HIV Infections

Other

Alabama

Deadline:

08/30/2026

Bodewell Products for the Treatment of Atopic Dermatitis

by CTG

in Atopic Dermatitis

Other

Alabama

Deadline:

02/01/2027

LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

by CTG

in Langerhans Cell Histiocytosis

Other

Alabama

Deadline:

07/01/2026

NEUROMARK Registry Study

by CTG

in Chronic Rhinitis

Other

Alabama

Deadline:

09/01/2027

Diet and Cognitive Training in Hematologic Cancer Survivors

by CTG

in Hematologic Malignancy, Cognitive Impairment

Other

Alabama

Deadline:

04/30/2027

A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

by CTG

in Lupus Nephritis, Lupus Erythematosus, Systemic

Other

Alabama

Deadline:

06/15/2032

PREVENT ALL ALS Study

by CTG

in Amyotrophic Lateral Sclerosis

Other

Alabama

Deadline:

07/25/2029

Equity in Prevention and Progression of Hypertension by Addressing Barriers to Nutrition and Physical activitY

by CTG

in Hypertension, Blood Pressure, Prehypertension

Other

Alabama

Deadline:

09/01/2026

Load more All clinical trials loaded.